Drugs News and Research

RSS

Russian Foreign Minister says country's HIV/AIDS problem is being 'aggravated' by U.S., NATO refusal to eradicate poppy crops in Afghanistan

Speaking on Monday at a conference on communicable diseases in the eastern Europe and Central Asia region, where AIDS is a growing problem, Russian Foreign Minister Sergei Lavrov made Russia's case for poppy crop eradication by U.S. and NATO forces in Afghanistan asserting that the West "is aggravating the HIV/AIDS problem in Russia and the West by refusing to use its forces to destroy opium crops in Afghanistan," Reuters reports.

12 Oct 2011

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology, has been granted US Patent 8,012,414 B2. The patent, dated September 6, 2011 entitled “Sterilization of Drugs Using Supercritical Carbon Dioxide Sterilant”, covers a new and effective method of sterilizing pharmaceutical product without dangerous chemicals or radiation.

11 Oct 2011

Health situation grim as Greece weathers economic crisis

Researchers warn that the health of people in Greece could be in danger in the wake of the financial crisis. Writing in The Lancet, they said cuts to hospitals' budgets meant they were being overstretched.

11 Oct 2011

Antivirulence drugs may fight infection and suppress resistance

Antivirulence drugs disarm pathogens rather than kill them, and although they could be effective in theory, antivirulence drugs have never been tested in humans. A new study to be published in the online journal mBio- on Tuesday, October 18 reveals these drugs have the potential to fight infection while avoiding the pitfalls of drug resistance.

11 Oct 2011

CRN responds to study on dietary supplements in older women

In response to the published study, "Dietary Supplements and Mortality Rate in Older Women," published in the Archives of Internal Medicine (a publication of the American Medical Association), the Council for Responsible Nutrition (CRN), the leading trade association representing the dietary supplement industry, issued the following two-part statement.

11 Oct 2011

First Edition: October 11, 2011

Today's headlines include reports about how Mitt Romney taking heat from the other GOP hopefuls, with some of the fire focusing on his Massachusetts health overhaul.

11 Oct 2011

Receptor tyrosine kinases control PI3K signaling in human KRAS mutant colorectal cancers

Some cancers can be effectively treated with drugs inhibiting proteins known as receptor tyrosine kinases, but not those cancers caused by mutations in the KRAS gene. A team of researchers led by Jeffrey Engelman, at Massachusetts General Hospital Cancer Center, Boston, has now identified a potential way to effectively use receptor tyrosine kinases inhibitors to treat individuals with KRAS mutant colorectal cancers - combine them with inhibitors of the MEK/ERK signaling pathway.

11 Oct 2011

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer

DARA BioSciences, Inc. today announced the Journal of Pain and Symptom Management, an internationally respected, peer-reviewed journal, has published results of a Phase II safety and efficacy study of KRN5500 for the treatment of neuropathic pain in patients with cancer.

11 Oct 2011

Statins hold promise against traumatic brain injury

Older patients who happened to have been taking cholesterol-lowering statin drugs when admitted to the hospital with serious head injuries were 76 percent more likely to survive than those not taking the drugs, according to results of a Johns Hopkins study.

11 Oct 2011

Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men

Use of selected prescription medications, including antidepressants, antihistamines, bronchodilators, anticholinergics, sympathomimetics, and diuretics contribute to 10 percent of lower urinary tract symptoms among men according to a Kaiser Permanente study published in the Archives of Internal Medicine.

11 Oct 2011

New DCE-CT technique gives better clues to future cardiac events in heart patients

A new non-invasive technique for measuring how well the heart and blood vessels function in patients already suffering from coronary artery disease could, in a single test, identify which abnormally narrowed blood vessels are the most likely to lead to further cardiovascular complications.

11 Oct 2011

Positive results from Biotron's BIT225 Phase 2a trial on HCV

Australian drug development company Biotron Limited has released headline results from its landmark Phase 2a trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients.

11 Oct 2011

Rare and severe hypoglycemia could be genetic

The life-threatening condition depicts the fact that the body does not have enough energy to function. Scientists at the University of Cambridge say mutations in the AKT2 gene are to blame. Writing in the journal Science, they say there are already cancer drugs which target a similar process.

10 Oct 2011

Merck’s diabetes combo pill gets FDA nod

The U.S. Food and Drug Administration (FDA) has approved Merck & Co.’s Juvisync diabetes drug, a combination pill for type 2 diabetes. Juvisync combines two Merck drugs already on the market, 1) glucose-lowering Januvia (Sitagliptin) medication and 2) cholesterol-lowering Zocor (Simvastatin).

10 Oct 2011

Patients with AF can benefit from Medtronic Phased RF Ablation System ablation system

Medtronic, Inc. today announced results from its Tailored Treatment of Permanent Atrial Fibrillation clinical trial, the first randomized study comparing ablation therapy with the Medtronic Phased RF Ablation System ablation system to traditional medical management in 210 patients with persistent or long-standing persistent atrial fibrillation.

From Medtronic 10 Oct 2011

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

A new study has found that an osteoporosis drug protects against the bone damaging side effects of certain breast cancer medications. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that some breast cancer patients could take zoledronic acid in addition to their anti-cancer medications to maintain bone health.

10 Oct 2011

Researchers examine effects of antirejection drugs in kidney transplant patients

Modern medicine's ability to save lives through organ transplantation has been revolutionized by the development of drugs that prevent the human body from rejecting the transplanted organ.

10 Oct 2011

New siRNA treatment reduces damaging inflammation in animals models of several disorders

Massachusetts General Hospital (MGH) researchers - along with collaborators from Massachusetts Institute of Technology (MIT) and Alnylam Pharmaceuticals - have found a way to block, in an animal model, the damaging inflammation that contributes to many disease conditions.

10 Oct 2011

Researchers focus on gelatinase inhibitor compounds to treat neurological diseases

Results of a study by a group of University of Notre Dame researchers represent a promising step on the road to developing new drugs for a variety of neurological diseases.

10 Oct 2011

Caffeine may predict risk of drug abuse

Parents of young caffeine consumers take heed: that high-calorie energy drink or soda might present more than just obesity risk. In fact, according to a double-blind, placebo-controlled study that examined responses to stimulants, an individual's subjective response to caffeine may predict how he or she will respond to other stimulant drugs, possibly reflecting differences in risk for abuse of other more serious drugs of abuse, such as amphetamine and cocaine.

10 Oct 2011

Drugs News and Research

Russian Foreign Minister says country's HIV/AIDS problem is being 'aggravated' by U.S., NATO refusal to eradicate poppy crops in Afghanistan

NovaSterilis awarded patent for sterilization process for pharmaceutical API using supercritical carbon dioxide

Health situation grim as Greece weathers economic crisis

Antivirulence drugs may fight infection and suppress resistance

CRN responds to study on dietary supplements in older women

First Edition: October 11, 2011

Receptor tyrosine kinases control PI3K signaling in human KRAS mutant colorectal cancers

DARA BioSciences' KRN5500 reduces neuropathic pain in patients with cancer

Statins hold promise against traumatic brain injury

Selected prescription drugs contribute to 10% of lower urinary tract symptoms among men

New DCE-CT technique gives better clues to future cardiac events in heart patients

Positive results from Biotron's BIT225 Phase 2a trial on HCV

Rare and severe hypoglycemia could be genetic

Merck’s diabetes combo pill gets FDA nod

Patients with AF can benefit from Medtronic Phased RF Ablation System ablation system

Osteoporosis drug protects against bone damaging side effects of breast cancer medications

Researchers examine effects of antirejection drugs in kidney transplant patients

New siRNA treatment reduces damaging inflammation in animals models of several disorders

Researchers focus on gelatinase inhibitor compounds to treat neurological diseases

Caffeine may predict risk of drug abuse

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News